Mallory McKeon
Research Subjects
Mallory McKeon has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alice L. Tang
University of Cincinnati College of Medicine
1 shared publication - Chad A. Zender
Department of Otolaryngology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
1 shared publication - Dustin A. Silverman
Department of Otolaryngology–Head and Neck Surgery University of Cincinnati Cincinnati Ohio USA
1 shared publication Megha Mohanakrishnan
1 shared publication- Priscilla F. A. Pichardo1 shared publication
Latest Publications
- Open Access
- 29 October 2025
- Published by IntechOpen
Role of Circulating Tumor DNA (ctDNA) in Head and Neck Squamous Cell Carcinoma
Head and neck cancer is the sixth most common cancer worldwide with classically poor outcomes related to advanced disease at presentation. Despite improvements in treatment strategies, morbidity and mortality remain high among this patient population, with frequent disease recurrence and need for lifelong surveillance. Oropharyngeal squamous cell carcinoma (OPSCC), a disease historically associated with alcohol and tobacco abuse, has become increasingly prevalent in young, otherwise healthy patients related to chronic infection with human papillomavirus (HPV). Though this subset of patients has favorable response to therapy, patients’ young age and health status places them at higher risk for delayed diagnosis and represents a challenge for long-term cancer surveillance. Circulating tumor DNA (ctDNA) has recently gained traction as a potential surveillance tool and affords the opportunity to shift this paradigm. Herein, we delve into the current, though constantly evolving, knowledge surrounding ctDNA and its role in the management of patients with HPV-mediated squamous cell carcinoma of the head and neck.
- 29 October 2025
- Published by IntechOpen
Open AccessRole of Circulating Tumor DNA (ctDNA) in Head and Neck Squamous Cell Carcinoma
Head and neck cancer is the sixth most common cancer worldwide with classically poor outcomes related to advanced disease at presentation. Despite improvements in treatment strategies, morbidity and mortality remain high among this patient population, with frequent disease recurrence and need for lifelong surveillance. Oropharyngeal squamous cell carcinoma (OPSCC), a disease historically associated with alcohol and tobacco abuse, has become increasingly prevalent in young, otherwise healthy patients related to chronic infection with human papillomavirus (HPV). Though this subset of patients has favorable response to therapy, patients’ young age and health status places them at higher risk for delayed diagnosis and represents a challenge for long-term cancer surveillance. Circulating tumor DNA (ctDNA) has recently gained traction as a potential surveillance tool and affords the opportunity to shift this paradigm. Herein, we delve into the current, though constantly evolving, knowledge surrounding ctDNA and its role in the management of patients with HPV-mediated squamous cell carcinoma of the head and neck.